Preprint · OA
via OpenAlex
Lysosomal Dysfunction and α‐Synuclein Aggregation in Parkinson's Disease: Diagnostic Links
Tim E. Moors, Silvia Paciotti, Davide Chiasserini, Paolo Calabresi, Lucilla Parnetti, Tommaso Beccari, Wilma D. J. van de Berg
Movement Disorders · 2016 · ▲ 173 citations
Abstract
Lysosomal impairment is increasingly recognized as a central event in the pathophysiology of PD. Genetic associations between lysosomal storage disorders, including Gaucher disease and PD, highlight common risk factors and pathological mechanisms. Because the autophagy(definition)-lysosomal system is involved in the intralysosomal hydrolysis of dysfunctional proteins, lysosomal impairment may contribute to α-synuclein aggregation in PD. The degradation of α-synuclein is a complex process involving different proteolytic mechanisms depending on protein burden, folding, posttranslational modifications, and yet unknown factors. In this review, evidence for lysosomal dysfunction in PD and its intimate relationship with α-synuclein aggregation are discussed, after which the question of whether lysosomal proteins may serve as diagnostic biomarkers for PD is addressed. Changes in lysosomal enzymes, such as reduced glucocerebrosidase and cathepsin levels, have been observed in affected brain regions in PD patients. The detection of lysosomal proteins in CSF may provide a read-out of lysosomal dysfunction in PD and holds promise for the development of diagnostic PD biomarkers. Initial PD biomarker studies demonstrated altered lysosomal enzyme activities in CSF of PD patients when compared with controls. However, CSF lysosomal enzyme activities alone could not discriminate between PD patients and controls. The combination of CSF lysosomal markers with α-synuclein species and indicators of mitochondrial dysfunction(definition), inflammation, and other pathological proteins in PD may be able to facilitate a more accurate diagnosis of PD. Further CSF biomarker studies are needed to investigate the utility of CSF lysosomal proteins as measures of disease state and disease progression in PD. © 2016 International Parkinson and Movement Disorder Society.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1002/mds.26562
- Canonical
- link ↗
- Fetched
- 2026-10-21 MST
Cite this
APA
Moors, T.E., Paciotti, S., Chiasserini, D., Calabresi, P., Parnetti, L., Beccari, T., & Berg, W.D.J.V.D. (2016). Lysosomal Dysfunction and α‐Synuclein Aggregation in Parkinson's Disease: Diagnostic Links. <em>Movement Disorders</em>. https://doi.org/10.1002/mds.26562
Vancouver
Moors TE, Paciotti S, Chiasserini D, Calabresi P, Parnetti L, Beccari T, et al. Lysosomal Dysfunction and α‐Synuclein Aggregation in Parkinson's Disease: Diagnostic Links. Movement Disorders. 2016. doi:10.1002/mds.26562.
BibTeX
@unpublished{tim2016Lysoso,
title = {Lysosomal Dysfunction and α‐Synuclein Aggregation in Parkinson's Disease: Diagnostic Links},
author = {Tim E. Moors and Silvia Paciotti and Davide Chiasserini and Paolo Calabresi and Lucilla Parnetti and Tommaso Beccari and Wilma D. J. van de Berg},
journal = {Movement Disorders},
year = {2016},
doi = {10.1002/mds.26562},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Movement Disorders 2019
Open access · CC-BY
Longitudinal analyses of cerebrospinal fluid α‐Synuclein in prodromal and early Parkinson's disease
Translational Neurodegeneration 2026
Open access · CC-BY
The mitophagy-inflammasome axis: a shared pathological hub in Alzheimer’s and Parkinson’s diseases
Movement Disorders 2017
Preprint · OA
Diagnostic utility of cerebrospinal fluid α‐synuclein in Parkinson's disease: A systematic review and meta‐analysis
Movement Disorders 2014
Open access · CC-BY
Cerebrospinal fluid lysosomal enzymes and alpha‐synuclein in Parkinson's disease
International Journal of Molecular Sciences 2017
Open access · CC-BY
Potential Modes of Intercellular α-Synuclein Transmission
Frontiers in Aging Neuroscience 2021
Open access · CC-BY